How many drugs treat Bacteroides Endomyometritis?

Drug Landscape tracks 3 marketed treatments for Bacteroides Endomyometritis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/bacteroides-endomyometritis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Bacteroides Endomyometritis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bacteroides Endomyometritis (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Bacteroides Endomyometritis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Cleocin	clindamycin	Generic (originally Upjohn/Pfizer)	Lincosamide antibiotic	50S ribosomal protein L10	1970-01-01
Metro I.V. In Plastic Container	METRONIDAZOLE	Baxter	Nitroimidazole Antimicrobial [EPC]		1963-01-01
Metronidazol	Metronidazol	University of Oslo		Thioredoxin reductase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Bacteroides Endomyometritis
Baxter · 1 drug in Bacteroides Endomyometritis
Generic (originally Upjohn/Pfizer) · 1 drug in Bacteroides Endomyometritis
University of Oslo · 1 drug in Bacteroides Endomyometritis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Bacteroides Endomyometritis:

Cite this brief

Drug Landscape (2026). Bacteroides Endomyometritis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/bacteroides-endomyometritis. Accessed 2026-06-10.

Bacteroides Endomyometritis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing